Deciphera Pharmaceuticals, Llc NDCs and Package Codes
This page lists NDC package records associated with labeler code 73207 (Deciphera Pharmaceuticals, Llc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
8
Package NDCs
7
Products
7
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 7 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| QINLOCK Ripretinib 50 mg/1 TABLET | 73207-0101-30 | — | On market | View → |
| ROMVIMZA Vimseltinib 30 mg/1 CAPSULE | 73207-0304-40 | — | On market | View → |
| ROMVIMZA Vimseltinib 14 mg/1 CAPSULE | 73207-0302-40 | — | On market | View → |
| ROMVIMZA Vimseltinib 20 mg/1 CAPSULE | 73207-0303-40 | — | On market | View → |
| ROMVIMZA Vimseltinib 20 mg/1 CAPSULE | 73207-0303-40 | — | On market | View → |
| ROMVIMZA Vimseltinib 14 mg/1 CAPSULE | 73207-0302-40 | — | On market | View → |
| ROMVIMZA Vimseltinib 30 mg/1 CAPSULE | 73207-0304-40 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.